The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.

Conditions:   Malignancies;   Stomach Cancer;   Non-small Cell Lung Cancer;   Esophageal Cancer;   Breast Cancer;   Ovary Cancer;   Cervical Cancer
Intervention:   Drug: Apatinib
Sponsor:   Shandong Cancer Hospital and Institute
Recruiting

http://ift.tt/2E2ClYP